We're excited to be featured among top industry players at next week's SAE Media Group AI in Drug Discovery USA conference in Boston! Our CSO Alfie Brennan will be taking part in a panel discussion titled: 'Strategising the Next Stage of AI Integration into Drug Discovery and the Pharmaceutical Industry', alongside world-class leaders and scientists from Novo Nordisk, Recursion, and Envisagenics. The panel is at 4:10 PM EDT on Monday 21st and is a must-see for all conference attendees! #Evariste #AIDrugDiscovery #SyntheticLethality #TechBio
Evariste’s Post
More Relevant Posts
-
Join us at MEDICRES AI 2024 for an insightful session with Erdem Büyükbingöl. 'NEW DRUG DISCOVERY WITH BIG PHARMA AND UNIVERSITY STRATEGIC INTELLIGENCE' will delve into the pioneering collaboration between academia and the pharmaceutical industry, highlighting the role of strategic intelligence in accelerating the development of groundbreaking medications. This presentation is a must-see for anyone interested in the future of pharmacology and the innovative strategies driving forward drug discovery. Discover how these partnerships are shaping the next generation of medical treatments. Join Us Now: www.medicres.ai #MedicReSAI #medicresai2024 #drugdiscovery #artificialintelligence
-
-
MedicReS AI Scientific Director | Clinical Research | BigData Science | Prompt Engineering | Biostatistics | Post Graduate Education | Machine Learning | Artificial Intelligence | LLMs
Join us at MEDICRES AI 2024 for an insightful session with Erdem Büyükbingöl. 'NEW DRUG DISCOVERY WITH BIG PHARMA AND UNIVERSITY STRATEGIC INTELLIGENCE' will delve into the pioneering collaboration between academia and the pharmaceutical industry, highlighting the role of strategic intelligence in accelerating the development of groundbreaking medications. This presentation is a must-see for anyone interested in the future of pharmacology and the innovative strategies driving forward drug discovery. Discover how these partnerships are shaping the next generation of medical treatments. Join Us Now: www.medicres.ai #MedicReSAI #medicresai2024 #drugdiscovery #artificialintelligence
-
-
OniX - Connecting Ideas to Opportunities | Biotech Innovation Accelerator | Academic Research to Market | Strategic Partnerships | Funding Strategist
Unlock the potential of academic research innovation hubs and AI in pharmaceutical drug R&D with OniX. Discover how OniX bridges the gap between groundbreaking academic research and industry application to accelerate drug development in our latest blog post https://lnkd.in/eKGKEraQ
-
🚨 Last Call! Discover Unique Live Cell Insights in Our Exclusive Online Demo Tomorrow! 🚨 🔗 Register Now: https://lnkd.in/dr9C_aNa Attention scientists and researchers in the pharmaceutical drug development industry! Don't miss this unique opportunity to gain live cell insights that are revolutionizing early in vitro and translational research. Our online demo will provide a deep dive into innovative techniques transforming drug discovery and development. Unlock the future of pharmaceutical research with us. See you there! #Pharma #DrugDiscovery #InVitro #TranslationalResearch #LiveCellInsights #Webinar #LastCall
-
Biotech Entrepreneur and Leader, Founder of NImmune Biopharma, NASDAQ: LABP, Biotherapeutics, and The NIMML Institute.
Thrilled to be featured in Pharmaceutical Executive, discussing a topic I'm deeply passionate about: the AI revolution in drug discovery. This piece explores the broader implications of AI in biopharma - how TITAN-X is reshaping timelines, reducing development costs, improving success rates, and transforming patient outcomes with the next wave of potential blockbuster drugs targeting new mechanisms of action. I invite you to read the full article at the link below.
AI is revolutionizing drug discovery, and we're leading the charge! Our founder and CEO, Josep B., breaks down how the TITAN-X platform is accelerating precision I&I drug development in Pharmaceutical Executive. Discover how we're using AI to fast-track life-changing therapies and reshape the future of precision medicine. Read the full article: https://lnkd.in/gZ2RKBrD #AIinDrugDiscovery #PrecisionMedicine #BiopharmaInnovation
-
-
As a global product development partnership, MMV plays a crucial role in engaging the pharmaceutical industry and academic research institutions to discover, develop and deliver new drugs to defeat #malaria. A recent paper co-authored by MMV’s Anna Adam, Elodie Chenu and Dominique Besson provides an overview of how we engage in drug discovery partnerships, our compound management network, open science initiatives and more. Read the article, published in SLAS (Society for Laboratory Automation and Screening): bit.ly/4cD6jT3
-
-
AI-Powered Drug Discovery: Revolutionizing Medicine" MIT researchers have developed the SPARROW algorithm, which leverages AI to identify the most promising molecules for new medicines. This innovative approach significantly speeds up the drug discovery process, potentially leading to faster development of life-saving treatments. Read more about how AI is transforming the pharmaceutical industry here: https://lnkd.in/gD-PX5mE
-
-
Tap into the potential of Generative AI in Drug Discovery! Discover the five key roles this groundbreaking technology plays in advancing pharmaceutical research. Dive into our latest post to revolutionize your approach to drug discovery with AI! https://lnkd.in/gmdr2KNX #GenerativeAI #DrugDiscovery #InnovativeTechnology
-
Editor in Chief, Partner, Pharma's Almanac, and Chief Science Officer, Partner, That's Nice
Discover how cross-industry innovations are transforming drug development in pharma—check out Pharma's Almanac roundtable with insights from industry leaders! 🚀
🌟 𝑱𝒐𝒊𝒏 𝒕𝒉𝒆 𝑪𝒐𝒏𝒗𝒆𝒓𝒔𝒂𝒕𝒊𝒐𝒏: 𝑯𝒐𝒘 𝒊𝒔 𝒕𝒉𝒆 𝒑𝒉𝒂𝒓𝒎𝒂 𝒊𝒏𝒅𝒖𝒔𝒕𝒓𝒚 𝒊𝒏𝒕𝒆𝒈𝒓𝒂𝒕𝒊𝒏𝒈 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏𝒔 𝒇𝒓𝒐𝒎 𝒂𝒅𝒋𝒂𝒄𝒆𝒏𝒕 𝒊𝒏𝒅𝒖𝒔𝒕𝒓𝒊𝒆𝒔 𝒕𝒐 𝒆𝒏𝒉𝒂𝒏𝒄𝒆 𝒅𝒓𝒖𝒈 𝒅𝒆𝒗𝒆𝒍𝒐𝒑𝒎𝒆𝒏𝒕? 🌟 Curious about how the pharmaceutical industry is evolving with insights from other sectors? In this Pharma's Almanac roundtable, a panel of industry experts share their insights on latest innovations shaping the biopharma sector. 🔗 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐫𝐨𝐮𝐧𝐝𝐭𝐚𝐛𝐥𝐞 𝐡𝐞𝐫𝐞: https://lnkd.in/e4Z_acjV Our roundtable features contributors from: Kosten Digital, Lonza, Likarda, Germfree, ScaleReady, Gelteq, Lifecore Biomedical, Refeyn, Navin Molecular, Samsung Biologics, Elixirgen Therapeutics, Inc., Quotient Therapeutics, Cytiva, Empress Therapeutics, Thermo Fisher Scientific, LabVantage Solutions, Inc, SciY, Roquette, ACD, and Bruker BioSpin. #PharmaInnovation #DrugDevelopment #PharmaceuticalIndustry #Roundtable #CDMO
-
-
Dive into Pharma's Almanac roundtable for insights from leading experts at companies like Lonza, Samsung Biologics, and Thermo Fisher Scientific. Discover how the pharmaceutical industry is harnessing fresh ideas from adjacent sectors to boost drug development!
🌟 𝑱𝒐𝒊𝒏 𝒕𝒉𝒆 𝑪𝒐𝒏𝒗𝒆𝒓𝒔𝒂𝒕𝒊𝒐𝒏: 𝑯𝒐𝒘 𝒊𝒔 𝒕𝒉𝒆 𝒑𝒉𝒂𝒓𝒎𝒂 𝒊𝒏𝒅𝒖𝒔𝒕𝒓𝒚 𝒊𝒏𝒕𝒆𝒈𝒓𝒂𝒕𝒊𝒏𝒈 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏𝒔 𝒇𝒓𝒐𝒎 𝒂𝒅𝒋𝒂𝒄𝒆𝒏𝒕 𝒊𝒏𝒅𝒖𝒔𝒕𝒓𝒊𝒆𝒔 𝒕𝒐 𝒆𝒏𝒉𝒂𝒏𝒄𝒆 𝒅𝒓𝒖𝒈 𝒅𝒆𝒗𝒆𝒍𝒐𝒑𝒎𝒆𝒏𝒕? 🌟 Curious about how the pharmaceutical industry is evolving with insights from other sectors? In this Pharma's Almanac roundtable, a panel of industry experts share their insights on latest innovations shaping the biopharma sector. 🔗 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐫𝐨𝐮𝐧𝐝𝐭𝐚𝐛𝐥𝐞 𝐡𝐞𝐫𝐞: https://lnkd.in/e4Z_acjV Our roundtable features contributors from: Kosten Digital, Lonza, Likarda, Germfree, ScaleReady, Gelteq, Lifecore Biomedical, Refeyn, Navin Molecular, Samsung Biologics, Elixirgen Therapeutics, Inc., Quotient Therapeutics, Cytiva, Empress Therapeutics, Thermo Fisher Scientific, LabVantage Solutions, Inc, SciY, Roquette, ACD, and Bruker BioSpin. #PharmaInnovation #DrugDevelopment #PharmaceuticalIndustry #Roundtable #CDMO
-
Business Developement Executive | Life Sciences Insurance Specialist | MRes Biomedical Science | Specialist Insurance Advisor to Life Science companies, providing Risk Management and Insurance Broking Services
1wExcited to see Evariste's progress discovering therapeutics for synthetic lethal oncological pathways. Hopefully you'll be at an event in London soon!?